We spoke to David Klenerman, co-developer of sequencing by synthesis, to find out how his work heralded the next generation ...

By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Swiss pharma and diagnostics giant Roche on Monday ...

Salvinia molesta can double its biomass in 36 hours. It spreads across ponds, lakes and slow-moving waterways in a smothering ...

SigmaIQ founder Duane Massie explains how AI is reshaping enterprise technology by creating value-led systems instead of ...

Tsingke Biotech recently hosted the Oligonucleotide Drug Salon at the Hilton Shanghai Zhangjiang, bringing together experts ...

As AI moves from prompts to agents, the focus is on optimising Human-AI workflows. That’s simply an AI evolution of ...

For more than three decades, researchers studying genomes have relied on foundational resources such as Repbase and, more ...

In the 1970s, American Fireworks, a family-run pyrotechnics company in Hudson, Ohio, used a “home run box” to offer quick and ...

Roche Holding AG is looking to take a share of Illumina Inc.’s dominance in the gene sequencing market with the launch of Axelios 1, its next-generation sequencing (NGS) platform designed for accuracy ...

Creative Director Andy Mac details Akai's legacy, the revival of its iconic product line, and the viral craze surrounding the ...

When it comes to finding answers, every moment counts—especially in critical care settings like the neonatal and pediatric intensive care units (NICU and PICU). Although rapid genetic tests, whether ...

Roche debuts Axelios, a gene sequencer targeting academic and research facilities, to compete with Illumina's dominance in ...